These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


264 related items for PubMed ID: 12668856

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. IIb/IIIa platelet inhibitors in the management of coronary artery disease.
    Talley JD.
    J Ark Med Soc; 1996 Oct; 93(5):237-9. PubMed ID: 8908943
    [No Abstract] [Full Text] [Related]

  • 6. Platelet glycoprotein IIb/IIIa receptor blockade after coronary angioplasty.
    Khan SS, Forrester J.
    N Engl J Med; 1997 Oct 23; 337(17):1243; author reply 1244-5. PubMed ID: 9340527
    [No Abstract] [Full Text] [Related]

  • 7. Post-procedural patient management: prevention and management of bleeding complications.
    Aguirre F.
    J Invasive Cardiol; 1994 Oct 23; 6 Suppl A():34A-37A; discussion 54A-56A. PubMed ID: 10155093
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Diabetes, coronary intervention, and platelet glycoprotein IIb/IIIa blockade: the triad revisited.
    Tang WH, Lincoff AM.
    Circulation; 2004 Dec 14; 110(24):3618-20. PubMed ID: 15596556
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Platelet glycoprotein IIb/IIIa antagonists in percutaneous coronary interventions.
    Gambhir DS, Mukhopadhyay S.
    Indian Heart J; 2000 Dec 14; 52(5):524-32. PubMed ID: 11256774
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Early and late clinical outcome following coronary angioplasty performed with platelet glycoprotein IIb/IIIa receptor inhibition: the EPIC Trial results.
    Popma JJ, Satler LF.
    J Invasive Cardiol; 1994 Dec 14; 6 Suppl A():19A-28A; discussion 45A-50A. PubMed ID: 10155090
    [Abstract] [Full Text] [Related]

  • 20. Is heparin still necessary after primary angioplasty in the era of platelet glycoprotein IIb/IIIa receptor inhibitors? A review of the literature.
    Lettieri C, De Servi S, Buffoli F, Aroldi M, Baccaglioni N, Romano M, Tomasi L, Izzo A, Zanini R.
    J Cardiovasc Med (Hagerstown); 2006 Sep 14; 7(9):653-9. PubMed ID: 16932077
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 14.